Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method - Test2 - elhamkhani - TriplyDB

Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method

Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method

http://www.wikidata.org/entity/Q35644300

about

Drug-Induced Liver Injury: Twenty Five Cases of Acute Hepatitis Following Ingestion of Polygonum multiflorum Thunb Drug-induced liver injury: present and future Drug-Induced Liver Injury Network Causality Assessment: Criteria and Experience in the United States Liver Injury from Herbal, Dietary, and Weight Loss Supplements: a Review Herbal hepatotoxicity: challenges and pitfalls of causality assessment methods Review article: the management of autoimmune hepatitis beyond consensus guidelines Drug- and Herb-Induced Liver Injury in Clinical and Translational Hepatology: Causality Assessment Methods, Quo Vadis?Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives.Therapeutic efficacy of monthly subcutaneous injection of daclizumab in relapsing multiple sclerosis Profiles of serum cytokines in acute drug-induced liver injury and their prognostic significance Liver Function Test Abnormalities in Depressed Patients Treated with Antidepressants: A Real-World Systematic Observational Study in Psychiatric Settings Drug-induced liver injury: recent advances in diagnosis and risk assessment.Research Advances on Hepatotoxicity of Herbal Medicines in China Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review.Clinical and histological features of idiosyncratic acute liver injury caused by temozolomide.An automated causality assessment algorithm to detect drug-induced liver injury in electronic medical record data.Death and Liver Transplantation within Two Years of Onset of Drug-Induced Liver Injury.Azathioprine and 6-Mercaptopurine-induced Liver Injury: Clinical Features and Outcomes Spontaneous reports of assumed herbal hepatotoxicity by black cohosh: is the liver-unspecific Naranjo scale precise enough to ascertain causality?Evolution of the Food and Drug Administration approach to liver safety assessment for new drugs: current status and challenges.Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset.Hepatic safety of antibiotics used in primary care Clinical and histologic features of azithromycin-induced liver injury.Population-representative incidence of drug-induced acute liver failure based on an analysis of an integrated health care system.Identification and Characterization of Cefazolin-Induced Liver Injury.Causes, Features, and Outcomes of Drug-Induced Liver Injury in 69 Children from China.Herbal medicine-related hepatotoxicity Clinical Pattern of Tolvaptan-Associated Liver Injury in Subjects with Autosomal Dominant Polycystic Kidney Disease: Analysis of Clinical Trials Database Hepatotoxicity Associated with the Use of Anti-TNF-α Agents Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury.Drug-drug interactions with oral anti-HCV agents and idiosyncratic hepatotoxicity in the liver transplant setting.Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop Bleeding complications and liver injuries during phenprocoumon treatment: a multicentre prospective observational study in internal medicine departments Serum proteomic profiling in patients with drug-induced liver injury.Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury DILI: New Insights into Diagnosis and Management.Drug-induced liver injury caused by intravenously administered medications: the Drug-induced Liver Injury Network experience.Clinical and histopathologic features of fluoroquinolone-induced liver injury.Detection of anti-isoniazid and anti-cytochrome P450 antibodies in patients with isoniazid-induced liver failure Amoxicillin-Clavulanate-Induced Liver Injury.

P2860

Q24628066-E9854239-F64E-4847-80E1-80267080C475 Q24630227-0A97D101-71FC-428D-A240-E6ECBA648623 Q26767296-0060A87A-BE5A-45D4-803E-F033C9302C6D Q26781749-5F6EBCAC-42F9-4C78-92C4-77052F0257B7 Q26824747-6C3953EC-BF91-4DD3-8786-7B3E0EF7C356 Q26864272-57158C4A-B38C-4975-BD24-54FC9AC4A7C8 Q27030822-B0317BC2-8CFE-4EFF-A12A-8E82E3DE2804 Q27690772-6FDF16CB-585C-4064-9F87-75B9CAF33952 Q28066677-B34CFFE1-C6C9-4E6A-BF85-82907C6565DF Q28538041-A496263B-A4C4-42A0-8D7A-E68D0F6B62E3 Q28552027-5B789D1A-D41C-4C4A-999A-6B93FCB568AD Q30235089-CDE4B53A-2961-493E-84A7-BF93FAA2DDC1 Q30239062-D1EA3DE1-61F1-4A8D-9C2A-21A480197B09 Q30277969-1FF54592-780D-4C90-8411-C48966E550D7 Q30447260-AD3539EA-21FC-4E8A-8156-DB11E73CF08F Q30830530-E3C31C3D-2059-410B-84E4-0453B07B9DB5 Q33442111-4D5B182A-1EE7-456B-84C8-A35B2C3872B6 Q33894632-0459C9CF-9825-426F-905A-81CD0611CCDC Q34195170-B474AD9C-485D-436C-A229-0228C469F6F1 Q34417044-A1F2DBA1-3FE7-4DDE-B383-CD9CC96E15CB Q34848118-CEEA88A7-03C8-4B7A-8540-3384CAC95799 Q35037383-244339AE-85A3-44BD-8A6D-426FC987432A Q35064690-AAA798A2-03FB-42F5-B95F-1A0643429B06 Q35655664-DEEBD35D-8BBB-4F18-8A76-1D95E8D9B324 Q35756589-DEE84C4C-6DFD-4EB3-A9F2-4B227355D6BD Q35771883-31606E6F-4A56-4316-9CE5-51EE970C96D6 Q36033537-0AC1E524-9429-46C5-83FD-544DE7D070E2 Q36171663-832A3EE2-DBAB-41A3-8EBA-8B0CED3F5B35 Q36576535-13DBFDD1-5A07-4AB5-914C-13D3FF04BB0C Q36668300-D3E3C38C-CD32-4822-B5B2-13113ECEC9A3 Q36668891-1384B5F4-2514-4E4A-9AAA-BE0A8BE7DF9E Q36740188-4320F5BF-B332-4556-BB56-96F1B17B36EC Q36785642-1D529F11-CC21-49E9-9B52-B45E66B9C8DD Q36845657-60BA030C-7430-4FA0-9AD8-92E048459932 Q36845686-C5EC6C66-D0BD-4121-AEF9-5F86AC436396 Q36885006-8C823DA3-8474-43ED-A4DA-933642786B61 Q36927091-4C8132E8-3508-4C16-BF87-B8778A4007E1 Q37031426-125DBF7E-FF9C-4273-87FE-2E75011284BB Q37082852-E5E2FE6C-0F6D-4F1D-AC57-69015BD892C7 Q37095609-46E68A65-D254-4715-997C-12E3399DAE50

P2860

Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method

http://www.wikidata.org/entity/Q35644300

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Causality assessment in drug-i ...... af causality assessment method

@ast

Causality assessment in drug-i ...... af causality assessment method

@en

type

label

Causality assessment in drug-i ...... af causality assessment method

@ast

Causality assessment in drug-i ...... af causality assessment method

@en

prefLabel

Causality assessment in drug-i ...... af causality assessment method

@ast

Causality assessment in drug-i ...... af causality assessment method

@en

P1433

Q35644300-34E4DA02-4889-4851-9AA7-BCB113F614F7

P1476

Q35644300-49861459-BB91-44AC-ABF8-5CBF7BB333C2

P2093

Q35644300-0CF838C0-105E-44F2-9702-18E4DC14163C

Q35644300-0FB64807-6565-4E4E-B63F-A23612F26761

Q35644300-25E113C4-55E9-42B5-9DCE-0F5C004D9863

Q35644300-43D67C2B-0B94-46CE-A635-5426E0B47A30

Q35644300-6E88A72E-3D77-48CD-AC32-F000BC5873C3

Q35644300-A561EDDF-E64D-4EE6-8C8E-C172F4A719AF

Q35644300-B115FF0F-FDE9-4724-8ECD-605284290A54

Q35644300-CA0DC365-B166-4292-B688-2D3161AB3100

Q35644300-DA79C4E7-A53C-41FF-A9E3-AF82DDAADDC0

P2860

Q35644300-12D47BD9-AC79-4DD4-977A-E6FF11EDD01D

Q35644300-1D90EB27-6CAF-4DF8-8C26-D005223A1744

Q35644300-22302FBF-40F5-483B-9C26-66BA6C993500

Q35644300-35BE2696-6B5B-4DDE-9836-1C2C60B7A2A1

Q35644300-3AA43970-5C85-4F31-A6EC-7C6E74EE3438

Q35644300-48D8206A-FD3F-40EE-A6DC-0C3D98CEA0BD

Q35644300-4A147A13-83D2-401E-B6FC-C6F2E96CA1BC

Q35644300-4B65B658-2AB6-4903-B8A7-E1DFADCEA19C

Q35644300-4F52E3CF-1277-4753-9D63-18C8C30DD497

Q35644300-60674706-CE44-4175-AAC1-CCFCC86B7025

P304

Q35644300-E11BAD03-55CF-4087-920F-BA02AF134AB8

P31

Q35644300-9CD3E24A-4646-4219-818E-6F2D88C5FAE1

P356

Q35644300-47DC8FEB-EC74-4E5E-BDE1-B4C90FB52FCB

P407

Q35644300-F8937054-5A6A-4683-B4BC-ACAC6891367C

P433

Q35644300-D4755BA4-5D4C-48BD-AD5A-FAABC06910B2

P478

Q35644300-C939111F-BF0C-42B7-976F-3EC9274C26FE

P577

Q35644300-668CC04F-FD03-4184-9F6A-9EF6654F6FBD

P5875

Q35644300-51E37B29-5E6D-486D-A38D-115EE1161B9A

P698

Q35644300-8176CC16-3870-482B-B48E-5A6B270C6879

P932

Q35644300-5F1DF285-CDD4-4315-8599-3C6A70021BFA

P356

P1433

P1476

Causality assessment in drug-i ...... af causality assessment method

@en

P2093

Don C Rockey

http://www.w3.org/2001/XMLSchema#string

James Freston

http://www.w3.org/2001/XMLSchema#string

James Rochon

http://www.w3.org/2001/XMLSchema#string

Leonard B Seeff

http://www.w3.org/2001/XMLSchema#string

Maurizio Bonacini

http://www.w3.org/2001/XMLSchema#string

Naga Chalasani

http://www.w3.org/2001/XMLSchema#string

Paul H Hayashi

http://www.w3.org/2001/XMLSchema#string

Robert J Fontana

http://www.w3.org/2001/XMLSchema#string

US Drug-Induced Liver Injury Network

http://www.w3.org/2001/XMLSchema#string

P2860

Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry

A method for estimating the probability of adverse drug reactions

Criteria of drug-induced liver disorders. Report of an international consensus meeting.

Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period.

Etiology of new-onset jaundice: how often is it caused by idiosyncratic drug-induced liver injury in the United States?

Immune-mediated drug-induced liver disease.

Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury.

Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct.

Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States.

Inpatient admissions for drug-induced liver injury: results from a single center.

P304

2117-2126

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.23577

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44640170

http://www.w3.org/2001/XMLSchema#string

P698

20512999

http://www.w3.org/2001/XMLSchema#string

P932

3249230

http://www.w3.org/2001/XMLSchema#string